MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.70
+0.47 (2.58%)
May 27, 2026, 10:13 AM EDT - Market open

MLTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
-46.46-41.97-30.32-22.32-23.01-
Research & Development
-220.92-202.86-112.77-31.8-42.05-
Other Operating Expenses
-267.37-244.83-143.09-54.12-65.06-
Total Operating Expenses
-534.75-489.67-286.18-108.25-130.120
Operating Income
-267.37-244.83-143.09-54.12-65.06-
Interest Expense
-9.5-7.25----
Other Non-Operating Income (Expense)
18.4822.3722.1310.140.59-
Total Non-Operating Income (Expense)
8.9815.1222.1310.140.59-
Pretax Income
-258.39-229.71-120.96-43.99-64.47-
Provision for Income Taxes
1.080.610.280.090.04-
Net Income
-132.13-227.32-118.94-36.01-64.51-4.54
Minority Interest in Earnings
-0.59-3-2.31-8.07--
Net Income to Common
-132.13-227.32-118.94-36.01-64.51-4.54
Shares Outstanding (Basic)
676463493811
Shares Outstanding (Diluted)
676463493811
Shares Change (YoY)
283.36%2.54%27.99%29.46%252.97%-
EPS (Basic)
-3.86-3.53-1.89-0.73-1.70-1.01
EPS (Diluted)
-3.86-3.53-1.89-0.73-1.70-1.01
Shares Outstanding
72.1371.3763.0860.4738.983.31
Free Cash Flow
-224.15-196.04-117.11-43.06-55.91-0.61
Free Cash Flow Per Share
-3.37-3.04-1.86-0.88-1.47-0.06
EBITDA
-264.29-242.22-141.71-53.75-64.90
EBIT
-267.37-244.83-143.09-54.12-65.06-
Effective Tax Rate
-0.42%-0.27%-0.23%-0.21%-0.06%-
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q